Advanced search
Publication Cover
Journal of Chemotherapy Volume 36, 2024 - Issue 4
Submit an article Journal homepage
745
Views
0
CrossRef citations to date
0
Altmetric
Case Reports

Benefit from Almonertinib after Osimertinib treat EGFR 19 exon deletion NSCLC induced Severe rash: a case report

Qichen Zhanga University of Lanzhou of the First School of Clinical Medicine, Lanzhou, ChinaView further author information
,
Peng Xieb Department of Radiation Oncology, The First Hospital of Lanzhou University, Lanzhou, ChinaView further author information
,
Xiaoming Houc Department of Oncology, The First Hospital of Lanzhou University, Lanzhou, ChinaView further author information
,
Chengpeng Zhaoc Department of Oncology, The First Hospital of Lanzhou University, Lanzhou, ChinaView further author information
,
Ling Duanc Department of Oncology, The First Hospital of Lanzhou University, Lanzhou, ChinaView further author information
&
Hui Qiaoc Department of Oncology, The First Hospital of Lanzhou University, Lanzhou, China;d School of Life Sciences, Lanzhou University, Lanzhou, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2347-4826View further author information
ORCID Icon
Pages 334-342 | Received 18 May 2023, Accepted 24 Oct 2023, Published online: 01 Nov 2023

Reprints and Permissions

Taylor & Francis does not sell reprints or permissions for this article. Please refer to the 'Licensing' tab on the article menu bar for information on the reuse conditions associated with this license type.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.